For example, activation of the PI3K/Akt pathway exacerbates hepatic steatosis due to increases in SREBP-mediated fatty acid and lipid synthesis [504–506] and drives inflammation in hepatic Kupffer cells through NLRP3 activation [507]. The gene discussed is AKT1; the disease is fatty liver disease.